|
Gary Reznik, M.D., F.A.C.C. |


|
Academy Clinical Research Specializing in Phase I—IV Clinical Trials |
|
Medical Director and Principal Investigator Dr. Gary Reznik is Board Certified in Internal Medicine and Cardiology. He completed his residency at Cedar Sinai and fellowship in Cardiology at the University of California, Irvine in 1994 and his training in Interventional Cardiology in 1995. · Dr. Reznik has many Professional Awards including the following: · Solomon Scholars Resident Research Award – 1991 · American College of Physicians Resident Research Presentation, 1991 · Paul Rubinstein Prize for Resident Research, Certificate of Participation, Cedars-Sinai Medical Center – 1991 Dr. Gary Reznik has authored and co-authored numerous publications and has participated in more than 100 clinical trials. His in-depth clinical trial education includes extensive ICH-GCP Training. Medical Monitoring Training and CITI Certification. In addition to clinical research, he has been the Assistant Clinical Professor of Medicine, Division of Cardiology at the University of California, Irvine. He is well-recognized in the pharmaceutical industry, having successfully conducted clinical trials in Los Angeles, California and served as a Medical Monitor and the head of Pharmocovigilance for worldwide clinical trials since 1995. |